RxSight, Inc.
For the period ended Sep 30, 2026. Filed Nov 3, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 3, 2026
RXST$4.540.0%Stored close · as of Nov 6, 2026
Contents
Condensed Consolidated Balance Sheets
(In thousands, except share and per share amounts)
| September 30, · December 31, | |||
|---|---|---|---|
| 2026 · 2025 | |||
| (Unaudited) | |||
| Assets | |||
| Current assets: | |||
| Cash and cash equivalents | $66,717 | $19,949 | |
| Short-term investments | 187,966 | 208,179 | |
| Accounts receivable, net | 16,998 | 23,383 | |
| Inventories | 39,593 | 31,559 | |
| Prepaid and other current assets | 3,530 | 4,389 | |
| Total current assets | 314,804 | 287,459 | |
| Property and equipment, net | 14,649 | 13,056 | |
| Operating leases right-of-use assets | 9,246 | 9,959 | |
| Restricted cash | 750 | 750 | |
| Other assets | 969 | 590 | |
| Total assets | $340,418 | $311,814 | |
| Liabilities and stockholders' equity | |||
| Current liabilities: | |||
| Accounts payable | $3,423 | $5,296 | |
| Accrued expenses and other current liabilities | 15,189 | 16,274 | |
| Deferred revenue, current | 4,496 | 3,521 | |
| Lease liabilities | 1,844 | 1,162 | |
| Refund liability | 50,000 | — | |
| Total current liabilities | 74,952 | 26,253 | |
| Long-term lease liabilities | 8,476 | 9,878 | |
| Deferred revenue, noncurrent | 2,079 | — | |
| Total liabilities | 85,507 | 36,131 | |
| Commitments and contingencies (Note 8) | |||
| Stockholders' equity: | |||
| Common stock, $0.001 par value, 900,000,000 shares authorized, 41,927,222 shares issued and outstanding as of September 30, 2026 and 41,242,005 shares issued and outstanding as of December 31, 2025 | 42 | 41 | |
| Preferred stock, $0.001 par value, 100,000,000 shares authorized, no shares issued and outstanding as of September 30, 2026 and December 31, 2025 | — | ||
| Additional paid-in capital | 960,213 | 936,628 | |
| Accumulated other comprehensive (loss) income | (100) | 53 | |
| Accumulated deficit | (705,244) | (661,039) | |
| Total stockholders' equity | 254,911 | 275,683 | |
| Total liabilities and stockholders' equity | $340,418 | $311,814 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.